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Abstract
Background: Late stage cancer malignancies may result in severe skeletal muscle wasting, fatigue
and reduced quality of life. Resistance training may attenuate these derangements in cancer
patients, but how this hypertrophic response relates to normal muscle adaptations in healthy
subjects is unknown. Here, we determined the effect of resistance training on muscle mass and
myosin heavy chain (MHC) isoform composition in plantaris muscles from tumor-bearing (TB) rats.
Methods:  Age- and gender-matched Buffalo rats were used for all studies (n = 6/group).
Suspensions of Morris Hepatoma MH7777 cells or normal saline were injected subcutaneously into
the dorsum. Six weeks after cell implantation, muscles from TB rats were harvested, weighed and
processed for ATP-independent proteasome activity assays. Once tumor-induced atrophy had
been established, subgroups of TB rats underwent unilateral, functional overload (FO). Healthy,
sham-operated rats served as controls. After six weeks, the extent of plantaris hypertrophy was
calculated and MHC isoform compositions were determined by gel electrophoresis.
Results: Six weeks of tumor growth reduced body mass and the relative masses of gastrocnemius,
plantaris, tibialis anterior, extensor digitorum longus, and diaphragm muscles (p ≤ 0.05). Percent
reductions in body mass had a strong, negative correlation to final tumor size (r = -0.78). ATP-
independent proteasome activity was increased in plantaris muscles from TB rats (p ≤ 0.05). In
healthy rats, functional overload (FO) increased plantaris mass ~44% compared to the contralateral
control muscle, and increased the relative percentage of MHC type I and decreased the relative
percentage of MHC type IIb compared to the sham-operated controls (p ≤ 0.05). Importantly,
plantaris mass was increased ~24% in TB-FO rats and adaptations to MHC isoform composition
were consistent with normal, resistance-trained muscles.
Conclusion: Despite significant skeletal muscle derangements due to cancer, muscle retains the
capacity to respond normally to hypertrophic stimuli. Specifically, when challenged with functional
overload, plantaris muscles from TB rats displayed greater relative mass, increased percentages of
MHC type I and decreased percentages of MHC type IIb. Therefore, resistance training paradigms
should provide relative morphological and functional benefits to cancer patients suffering from
muscle wasting.
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Background
Cachexia is a debilitating condition associated with sev-
eral chronic disease states, including AIDS, cancer and
congestive heart failure [1], and manifests in severe body
wasting with specific insults to skeletal muscle. Cancer
cachexia, also known as wasting syndrome, is a paraneo-
plastic syndrome that afflicts approximately two thirds of
patients with advanced cancers and results in generalized
weakness, asthenia, and a decreased ability to tolerate
conventional therapies [2]. In fact, approximately 22–
30% of all cancer deaths are directly attributable to com-
plications arising from cachexia, primarily due to the dete-
rioration of respiratory musculature and subsequent
hypostatic pneumonia [3,4].
Invariably, the underlying cause of skeletal muscle wast-
ing due to cancer cachexia is a severe metabolic distur-
bance as tumor and host contend for nutrients and energy
substrates. While anorexia or reduced caloric intake may
contribute to this wasting process, nutritional interven-
tion strategies are often insufficient to prevent the devel-
opment of cachexia [5], which reflects the complex
pathology of the disease. Therefore, skeletal muscle wast-
ing in cachectic cancer patients has been attributed to fac-
tors independent of nutritional status, including
increased proinflammatory cytokines levels [2,6],
increased levels of tumor-derived factors [7], or altered
hormonal status [8]. Tumor-induced skeletal muscle pro-
tein loss appears to be due, in part, to increased activity of
the ATP-ubiquitin-dependent proteasome system [9-11].
Using the aggressive Yoshida ascites hepatoma to produce
rapid skeletal muscle atrophy, inhibition studies have sug-
gested that other proteolytic systems, such as Ca2+-acti-
vated calpain proteases, lysosomal proteases or the ATP-
independent-proteasome system, play only negligible
roles in acute tumor-induced atrophy [9,10]. However,
the regulation of skeletal muscle atrophy by the ATP-inde-
pendent proteasome system during chronic tumor devel-
opment remains poorly understood.
While the negative effects of cancer cachexia on skeletal
muscle mass are well-established, few studies have
attempted to identify the effects of cancer cachexia on
properties that influence muscle function such as myosin
heavy chain (MHC) isoform composition [12]. Certainly
in other experimental models associated with skeletal
muscle atrophy, increases in the relative distribution of
fast MHC isoforms are evident [13-15]. In contrast, exper-
imental models of resistance training (e.g., functional
overload (FO) of the plantaris muscle) are associated with
increased percentages of slower MHC isoforms [16].
While resistance training may attenuate muscle atrophy
and improve muscle strength in cancer patients [17], its
influence on MHC isoforms remains unresolved.
In these studies, we hypothesized that skeletal muscles
from rats bearing a tumor derived from Morris hepatoma
MH7777 cells would have increased ATP-independent
proteasome activity, which may contribute to systemic
skeletal muscle atrophy. We next tested the hypothesis
that FO would prevent plantaris muscle atrophy and stim-
ulate fast-to-slow MHC isoform transitions in tumor-
bearing (TB) rats, both of which are characteristics of
resistance-trained skeletal muscle [16]. Our data show
that cancer cachexia does not affect the capacity of skeletal
muscle to respond normally when challenged with a
hypertrophic stimulus. These data also suggest that resist-
ance training should provide relative morphological and




The Virginia Tech Animal Care Committee approved all
experimental procedures. Female Buffalo rats (~150–175
g) were purchased from Harlan Sprague Dawley (Indian-
apolis, IN). All rats were housed in pairs under a 12:12
light-dark cycle at room temperature and provided free
access to food (Harland Teklad 2018 rodent chow) and
water. Rats were randomly assigned to one of four groups
(n = 6/group): vehicle-injected, sham-operated (Veh);
vehicle-injected, FO (FO); tumor-bearing, sham-operated
(TB); and tumor-bearing, FO (TB-FO). Body, skeletal mus-
cle and tumor masses were obtained at termination.
Tumor model
The Morris hepatoma MH7777 cell line (ATCC #CRL-
1601) was used to induce tumor formation and has previ-
ously been used to study derangements associated with
cancer cachexia [18]. Cells were grown in Dulbecco's
Modified Eagle's Medium (4.5 g glucose/L, L-glutamine,
NaHCO3, and pyridoxine HCl) supplemented with 10%
fetal bovine serum and 50 µg/ml gentamycin and main-
tained at 37°C and 5% CO2. Cells were trypsinized in a
subconfluent state (~85–90% confluency), washed and
resuspended in sterile Dulbecco's phosphate-buffered
saline prior to injection. Rats in the TB groups received a
suspension of cells (106 cells/300 µl) implanted subcuta-
neously on the dorsal side above the hip using a 22-G 1.5"
needle. Pilot data indicated that this cell density and injec-
tion location produced average tumor masses of 6.36 ±
0.93 g after 4 weeks and significantly reduced skeletal
muscle masses after 6 weeks. Functional overload surger-
ies did not affect tumor development. Total food intake/
cage (data not shown) and common signs of distress (e.g.,
failure to groom) were monitored daily. Neither was
altered in TB rats nor in rats that underwent FO surgeries.
Control rats not receiving MH7777 cells were injected
with 300 µl of sterile Dulbecco's PBS solution.BMC Cancer 2007, 7:146 http://www.biomedcentral.com/1471-2407/7/146
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Muscle preparation
Six weeks after MH7777 cell or vehicle injection, rats were
anesthetized with intraperitoneal injections of Ketamine
(80 mg/kg) and Xylazine (10 mg/kg). Soleus, gastrocne-
mius, plantaris, tibialis anterior, extensor digitorum lon-
gus and diaphragm muscles were removed, trimmed free
of connective tissue and fat, blotted dry, weighed, frozen
in isopentane cooled in liquid nitrogen and stored at -
80°C until further analysis.
ATP-independent proteasome activity assay
The ATP-independent proteasome activity assay measures
fluorescence following chymotrypsin-like degradation of
the fluorometric substrate, Suc-Leu-Leu-Val-Tyr-AMC
(Bachem). This substrate has been used previously to ana-
lyze proteasome activity [19]. Briefly, fresh soleus and
plantaris muscles were homogenized in ten volumes of
buffer that contained: 1 M Tris (pH 7.6), 200 mM EDTA,
and 0.1% β-mercaptoethanol. Samples were then centri-
fuged at 12,000 rpm for 20 minutes at 4°C. Supernatants
were subjected to dialysis overnight at 4°C using Spectra/
Por® biotech membranes with a retention rating of 15,000
(Spectrum Laboratories, Inc.). The dialysis buffer con-
tained: 20 mM Tris (pH 7.6), 20 mM NaCl, 1 mM MgCl2,
0.1 mM EDTA, 0.5 mM DTT, and 20% glycerol. Dialysate
was then centrifuged at 15,200 g for 20 minutes at 4°C. A
Perkin-Elmer luminescence spectrophotometer LS-50-B
was set to an excitation wavelength of 380-nm and an
emission wavelength of 460 nm. Reaction buffer contain-
ing: 1 M Tris (pH 8.0), 50 µM Suc-Leu-Leu-Val-Tyr-AMC,
and 0.4% β-mercaptoethanol was warmed to 37°C prior
to usage. Five-µl dialysate supernatant was added to 1 ml
of reaction buffer in a glass cuvette. The reaction pro-
ceeded for 3 minutes and maximal ATP-independent pro-
teasome activity (AU/min) was measured on the steepest
part of the slope over a 20 second duration. Specific activ-
ities were adjusted for total protein content in each sam-
ple (AU/min/µg protein), as determined using the
Bradford protein assay [20].
Unilateral, functional overload surgeries
Unilateral, functional overload (FO) surgeries were per-
formed 5 days prior to the introduction of MH7777 cells
to avoid the inflammatory phase associated with this sur-
gery. Unilateral FO surgery spares the non-operated con-
tralateral leg to serve as an internal control, therefore
allowing for precise measurements of hypertrophy [21].
Rats were anesthetized with a gas mixture of 2 L/min iso-
fluorane and 3 L/min oxygen. Under aseptic conditions, a
midline incision was made through the skin on the poste-
rior aspect of the animal's lower leg on the same side as
MH7777 cell implantation. The distal tendon of the gas-
trocnemius muscle was isolated from the tendons of its
major synergists (soleus and plantaris) and transected.
The distal portion of the gastrocnemius was removed,
with particular care taken not to interrupt vasculature or
innervation leading to the soleus or plantaris muscles. The
skin was closed with 3-0 Ethilon suture. The incision was
treated with a topical antibiotic (Bacitracin). Rats were
returned to their cages and monitored daily for sudden
changes in health or temperament.
Electrophoretic separation of MHC isoforms
Frozen plantaris muscles were minced in 10 volumes of
buffer containing: 20 mM Tris (pH 6.8), 250 mM sucrose,
5 mM EDTA, and 100 mM KCl. Plantaris samples were
then homogenized by hand using glass tissue grinders
kept on ice. Total protein was assayed according to the
method of Bradford [20]. Protein samples were boiled for
2 minutes in buffer containing: 100 mM Tris-HCl (pH
6.8), 240 mM β-mercaptoethanol, 4.38 mM SDS, 3 µM
bromophenol blue, and 20% glycerol to a final total pro-
tein concentration of 0.125 mg/ml. MHC isoforms were
separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) as previously described [22].
Briefly, the stacking gel was composed of 30% glycerol,
4% acrylamide-N, N'-methylene-bis-acrylamide (bis)
(50:1), 70 mM Tris (pH 6.7), 4 mM EDTA, and 0.4% SDS.
The separating gel was composed of 30% glycerol, 8% acr-
ylamide-bis (50:1), 200 mM Tris (pH 8.8), 100 mM gly-
cine, and 4% SDS. Polymerization of the stacking and
separating gels was initiated by adding 0.05% N, N, N',
N'-tetramethylethylenediamine (TEMED) and 0.1%
ammonium persulfate. One-µg of total protein was
loaded per lane and separated in a Biorad mini-Protean 3
at a constant 70 volts supplied by a BioRad PowerPac 300
for 24 h. The mini-Protean 3 was stored at 4°C to mini-
mize temperature fluctuations. The gels were stained with
Coomasie Blue overnight at room temperature, destained
with a solution containing 40% methanol and 10% acetic
acid and analyzed with an Alpha Innotech IS-2000 video
densitometric system. MHC isoform composition was
expressed as percentages of the total MHC isoform pool.
Statistics
One-way analyses of variance were performed for compar-
isons between control and TB rats. Two-way analyses of
variance were performed for FO studies. These ANOVAs
were followed by Student-Newman-Keuls post-hoc tests.
All calculations were performed using SigmaStat v2.0 soft-
ware. Significance was accepted at p ≤ 0.05.
Results
Tumor morphology, body and muscle masses
Palpable tumors were evident ~16–19 days after MH7777
cell implantation. Final tumor masses after six weeks of
development averaged 12.3 ± 1.8 g, which corresponded
to ~10% of total carcass mass. TB rats lost an average of
5.21 ± 1.8% of their initial body mass (Figure 1A). In con-BMC Cancer 2007, 7:146 http://www.biomedcentral.com/1471-2407/7/146
Page 4 of 9
(page number not for citation purposes)
trast, age-, gender- and weight-matched, healthy controls
(Veh) gained an average of 5.3 ± 0.08% of body mass over
these six weeks. Tumor size and percent change from ini-
tial body mass displayed a strong, negative correlation of
r = -0.78 (Figure 1B).
Relative masses of several skeletal muscles were reduced,
including gastrocnemius, plantaris, tibialis anterior,
extensor digitorum longus and diaphragm (p ≤ 0.05).
However, the soleus muscle was spared from tumor-
induced atrophy (Figure 2).
ATP-independent proteasome activity
Because little is known about the role of the ATP-inde-
pendent proteasome component in tumor-induced skele-
tal muscle atrophy, we next determined the influence of
this proteolytic system in soleus and plantaris muscles
from TB rats. These two muscles were specifically chosen
for proteolytic activity measurements because of their
contrasting relative mass responses in TB rats (Figure 2).
As expected, specific ATP-independent proteasome activ-
ity in soleus muscles from TB showed no difference com-
pared to Veh (0.08 ± .01 vs. 0.09 ± 0.03 AU/min/µg,
respectively) (Figure 3B). In contrast, atrophied plantaris
muscles from TB rats had increased proteasome activity
compared to Veh (0.12 ± 0.02 vs. 0.07 ± 0.01 AU/min/µg,
respectively) (Figure 3A, B).
Influence of functional overload on plantaris mass
Because plantaris muscles were atrophied in TB rats, we
next attempted to attenuate these derangements by per-
Six weeks of tumor development induced skeletal muscle  atrophy Figure 2
Six weeks of tumor development induced skeletal 
muscle atrophy. Several skeletal muscles, including gas-
trocnemius, plantaris, tibialis anterior, extensor digitorum 
longus and diaphragm, had reduced relative masses that 
could not be attributed to reduced caloric intake or ano-
rexia. N = 6/group. *, Significantly different from control rats 
(p ≤ 0.05). TB, tumor-bearing.
Six weeks of tumor development induced body mass wasting Figure 1
Six weeks of tumor development induced body mass 
wasting. (A) Tumors derived from Morris hepatoma 
MH7777 cells that were implanted on the dorsum of rats and 
allowed to develop for six weeks produced significant body 
mass reductions compared to healthy controls. (B) A strong, 
negative correlation existed between final tumor size and the 
percentage of body mass loss. Dashed lines represent the 
95% confidence band. N = 6/group. *, Significantly different 
from control rats (p ≤ 0.05). TB, tumor-bearing.
A 
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forming functional overload (FO) surgeries to stimulate
growth. In healthy control rats, FO resulted in ~44%
increase in mass relative to the contralateral plantaris (Fig-
ure 4) (p ≤ 0.05). Likewise, FO in TB rats resulted in ~24%
increase in plantaris mass (p ≤ 0.05). Interestingly, there
was no difference in the hypertrophic response in
plantaris muscles from FO or TB-FO groups suggesting
that the intrinsic and extrinsic signaling mechanisms that
stimulate muscle hypertrophy are not affected by the
atrophic signals caused by the tumor (Figure 2).
Influence of functional overload on MHC isoform 
composition
In healthy rats, plantaris muscles subjected to FO had
increased relative percentages of slow, MHC type I iso-
form (9.0 ± 0.3% vs. 6.4 ± 0.8%, respectively) and
decreased relative percentages of fast, MHC type IIb (40.8
± 1.4% vs. 47.9 ± 1.3%, respectively) compared to sham-
operated controls (Figure 5) (p ≤ 0.05). In sham-operated
TB rats, plantaris muscles had decreased relative percent-
ages of MHC type I compared to muscles from sham-oper-
ated healthy controls (2.9 ± 0.9% vs. 6.4 ± 0.8%,
respectively) (p ≤ 0.05). However, plantaris muscles from
TB-FO rats displayed increased relative percentages of
MHC type I (8.2 ± 0.3% vs. 2.9 ± 0.9%, respectively) and
decreased relative percentages of MHC type IIb (39.7 ±
1.6% vs. 51.6 ± 1.8%, respectively) compared plantaris
Functional overload successfully prevents plantaris atrophy in  TB rats Figure 4
Functional overload successfully prevents plantaris 
atrophy in TB rats. Six weeks after functional overload 
surgeries were performed plantaris muscle masses were 
increased relative to contralateral control muscles, regard-
less of health status. N = 6/group. *, Significantly different 
from sham-operated control rats (p ≤ 0.05). #, Significantly 
different from sham-operated TB rats (p ≤ 0.05). FO, func-
tional overload; TB, tumor-bearing.
ATP-independent proteasome activity is stimulated in  plantaris muscles from tumor-bearing (TB) rats Figure 3
ATP-independent proteasome activity is stimulated 
in plantaris muscles from tumor-bearing (TB) rats. 
(A) Representative example of specific ATP-independent 
proteasome activity from plantaris muscles from TB and con-
trol rats. The sharp peaks between 22–30 seconds reflect the 
introduction of samples into the cuvette. Measurements of 
ATP-independent proteasome activity were made during the 
steepest part of the subsequent slope over a 20 second win-
dow. (B) Plantaris, but not soleus muscles, displayed 
increased relative proteasome activity due to the presence of 
the tumor. These data are expected considering that the 
soleus muscle was resistant to tumor-induced atrophy (Fig-
ure 2). N = 6/group. *, Significantly different from control 
rats (p ≤ 0.05).
A
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muscles from sham-operated TB rats (p ≤ 0.05). Similar to
the hypertrophic responses due to FO (Figure 4), no dif-
ference was detected in the relative MHC isoform profiles
in plantaris muscles from FO or TB-FO rats.
Discussion
We showed that tumor-bearing (TB) rats had significantly
reduced body and skeletal muscle masses. Atrophied skel-
etal muscles from TB rats were also associated with
increased ATP-independent proteasome activity. Impor-
tantly, the major finding of this study was that, despite the
underlying atrophic effects produced by the tumor, skele-
tal muscle retains its ability to adapt to increased loading,
including hypertrophy and establishment of a slower
MHC isoform profile.
Influence of tumor on body and skeletal muscle masses
Rats that developed solid tumors six weeks after subcuta-
neous implantation of Morris hepatoma MH7777 cells
had ~5% decrease in body mass relative to initial body
mass. This wasting was due, in part, to atrophy of several
skeletal muscles, including gastrocnemius, plantaris,
extensor digitorum longus, tibialis anterior and dia-
phragm. Importantly, the presence of the tumor did not
appear to alter food intake nor did the location of the
tumor on the dorsum restrict normal muscle growth (e.g.,
crush injury). Therefore, the decrease in body and skeletal
muscle masses were likely due to systemic responses.
Studies using other models of cancer cachexia-producing
cell lines, including Yoshida AH-130 rat ascites hepatoma
or C26 adenocarcinoma cell lines, despite having different
tumor incubation periods, have reported similar magni-
tudes of wasting [9,12]. Together, these reports support
the notion that cancer cachexia may produce general sys-
temic atrophy. Interestingly, the soleus muscle appeared
to be spared from tumor-induced atrophy. Because the
soleus is a principle postural muscle in the hindlimb of
rats, the location of the tumor on the dorsum of the rats
and the extra mass it forced the animal to support may
have provided a significant stimulus to prevent atrophy.
This explanation seems reasonable when one considers
that final tumor masses averaged 12.3 g, which corre-
sponded to ~10% of total body weight. Alternatively, a
longer duration of tumor growth may have been required
to produce significant soleus atrophy. Interestingly, mice
injected with murine C26 adenocarcinoma cells experi-
enced significant soleus atrophy [12]. This apparent dis-
crepancy with the current study may be due, in part, to the
differing MHC isoform compositions between rat and
mouse soleus muscles. The comparatively slower MHC
phenotype of the rat soleus may have provided some
measure of protection against tumor-induced atrophy.
Tumor-induced muscle atrophy appeared to be due, in
part, to increased proteasome activity. Previous studies
have demonstrated that the ATP-dependent-ubiquitin-
proteasome pathway plays a central role in regulating
muscle atrophy associated with cancer cachexia [9,23].
This pathway may be stimulated by a variety of tumor-
induced agents, such as glucocorticoids, inflammatory
cytokines, proteolysis-inducing factor (PIF), or oxidative
stress [23]. Here, we showed that ATP-independent pro-
teasome activities were stimulated in plantaris muscles
from TB rats. Not surprisingly, there was no difference in
proteasome activity in soleus muscles from TB rats, which
did not experience tumor-induced atrophy. While metal-
loprotease or serine proteases may be responsible for ATP-
independent proteasome activity [24], their target sub-
strates are still largely undefined. However, myoglobin,
Functional overload normalizes myosin heavy chain isoform  profiles in TB rats Figure 5
Functional overload normalizes myosin heavy chain 
isoform profiles in TB rats. Plantaris muscles from TB 
rats had decreased relative percentages of slow, MHC type I 
isoform which is suggestive of a faster MHC isoform profile. 
Similar to healthy rats, six weeks after functional overload 
surgeries were performed plantaris muscle from TB rats had 
increased relative percentages of slow, MHC type I isoform 
and decreased relative percentages of fast, MHC type IIb iso-
form. In fact, the MHC isoform profiles were similar in 
plantaris muscles from control or TB rats following FO sur-
geries. N = 6/group. *, Significantly different from sham-oper-
ated control rats (p ≤ 0.05). #, Significantly different from 
sham-operated TB rats (p ≤ 0.05). FO, functional overload; 
TB, tumor-bearing.
 Sham      TB     FO     TB+FO IIa
IIx
IIb
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the primary oxygen-carrying protein primarily expressed
in oxidative skeletal muscle, appears to be primarily
degraded by ATP-independent proteolytic mechanisms
[24]. Interestingly, we show that plantaris muscles from
TB rats may be becoming less oxidative, based on MHC
isoform expression profiles. Certainly, adaptation to
MHC isoform composition and metabolism may occur
independently [14], but one possible explanation for this
transition toward a more fatigable profile may be due, in
part, to ATP-independent degradation of myoglobin.
Influence of FO interventions on plantaris mass
Several laboratories have reported ~30–100% increases in
plantaris muscle mass following various durations of
compensatory hypertrophy [25]. In our healthy rats, six
weeks after FO surgeries, plantaris muscles were ~44%
larger than contralateral controls. Importantly, FO
plantaris muscles from TB rats increased in relative mass
by ~24% compared to muscles from sham-operated TB
rats. In concert with our results, electrical stimulation of
extensor digitorum longus muscles from tumor-bearing
mice attenuated muscle wasting and protein depletion
[26], which suggests that the normal hypertrophic signal-
ing mechanisms and the capacity of skeletal muscle to
respond to these signals remains intact. Yet, gene expres-
sion of insulin-like growth factor-1 (IGF-1), a potent ana-
bolic hormone, was down-regulated in skeletal muscles
from tumor bearing rats [8]. Indeed, more work is
required to clarify the effects of resistance training on
hypertrophic signal mechanisms in cancer patients.
Influence of FO interventions on MHC isoform 
composition
Myosin heavy chain isoform composition is regulated, in
part, by the amount and pattern of electrical activity a
muscle receives [27]. For example, reduced neuromuscu-
lar activity due to spinal cord transection [14] or spinal
cord isolation [28] increases the percentage of fast fiber-
like protein phenotypes. In contrast, increased neuromus-
cular activation due to tonic, low frequency stimulation
[29] or FO [16] induces the slow fiber-like protein pheno-
type. Importantly, tumors were not located near motor
neurons that innervate the plantaris. Therefore, the con-
ductance of electrical activity from the spinal cord to the
plantaris was likely unaltered. This is supported by the
observation that TB rats appeared pain-free and ambu-
lated normally.
Myosin heavy chain isoform expression patterns have also
been linked to mechanisms independent of neuromuscu-
lar activity. For example, increased plasma TNF-α levels
have been shown to induce a faster MHC isoform profile
in tibialis anterior muscles from rats with congestive heart
failure [30]. Interestingly, levels of TNF-α are increased in
cachectic cancer patients [31,32] and are elevated in severe
combined immunodeficient (SCID) mice implanted with
Morris hepatoma MH7777 cells [33]. Therefore, tumor-
induced cytokines, such as TNF-α, may be responsible for
the faster MHC isoform profile evident in plantaris mus-
cles from TB rats. Because these cytokines are also impli-
cated in stimulating proteasome activity [23], the
susceptibility of specific isoforms to proteasome-medi-
ated degradation may influence the overall MHC profile.
However, neither translational nor post-translational pro-
tein modifications appear to be responsible for the slow-
to-fast MHC isoform transition that occurs in TB animals
[12]. Interestingly, plantaris muscles from mice bearing a
murine C-26 adenocarcinoma showed no change to MHC
isoform composition. This apparent discrepancy with the
current study might be due to the different animal models
used (mouse vs. rat), the different cell lines used to induce
tumor formation (murine C-26 adenocarcinoma vs.
MH7777 hepatoma cells), duration of tumor develop-
ment, and/or the level of physical activity of the animals.
Importantly, plantaris muscles from TB rats retain the
capacity to establish a slow MHC fiber profile comparable
to that of resistance-trained muscle from healthy animals.
The establishment of a slower MHC isoform profile may
have significant physiological consequences, such as
increased resistance to fatigue, improved oxidative capac-
ities, and exercise tolerance [34,35]. In muscles from
healthy animals, transitions toward a slower MHC iso-
form profile have been attributed to a variety of factors
that are sensitive to increased neuromuscular activity,
such as the Ca2+-dependent phosphatase calcineurin [36]
or peroxisome-proliferator-activated receptor-γ co-activa-
tor-1 (PGC-1α) [37]. Recently, skeletal muscle atrophy
due to cancer cachexia has been linked to reduced PGC-1α
gene expression [38]. Because PGC-1α expression is stim-
ulated by exercise [38,39], this transcription factor may
provide an intriguing target to ultimately reduce the skel-
etal muscle derangements associated cancer cachexia.
Conclusion
We have demonstrated that the decline in muscle mass in
TB rats may be due, in part, to increased ATP-independent
proteasome activity. Further, tumor-induced atrophy can
be attenuated by an experimental model of resistance
training. Resistance training may also normalize tumor-
induced alterations to MHC isoform composition. In fact,
the morphological gains achieved from FO in the
plantaris muscle from TB rats were comparable to those
from healthy controls. These data suggest that resistance
training may provide relative benefits to cancer patients,
including decreased weakness due to atrophy, improved
tolerance to conventional therapies, and a better quality
of life.BMC Cancer 2007, 7:146 http://www.biomedcentral.com/1471-2407/7/146
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